Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial
Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, Okano M, Kagoshima M, Tsuchida T
Published in European Journal of Clinical Nutrition
Methodology
Twelve-week multicentre randomised controlled trial of fermented milk containing Lactobacillus gasseri SBT2055 in adults with obese tendencies, with abdominal fat measured by computed tomography
Key Findings
Visceral and subcutaneous fat areas decreased significantly with LG2055 compared with control, alongside reductions in body weight and waist circumference.
Conclusions
L. gasseri SBT2055 reduced abdominal adiposity over 12 weeks in adults with obese tendencies.
Limitations
Fat gains rebounded after cessation; single manufacturer conducted the trial.
Supplements Studied
Visceral and subcutaneous fat areas decreased significantly with LG2055 compared with control, alongside reductions in body weight and waist circumference.
Visceral and subcutaneous fat areas decreased significantly with LG2055 compared with control, alongside reductions in body weight and waist circumference.
Outcomes Measured
Visceral and subcutaneous fat areas decreased significantly with LG2055 compared with control, alongside reductions in body weight and waist circumference.
Visceral and subcutaneous fat areas decreased significantly with LG2055 compared with control, alongside reductions in body weight and waist circumference.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.